eMJA: Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?

Editorials

Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?

Robyn L Woods, Andrew M Tonkin, Mark R Nelson, Helena C Britt and Christopher M Reid

MJA 2009; 190 (11): 614-615

Robust evidence remains to be gathered

Whenever possible, clinical decision making should be evidence-based. In reality, the evidence may be incomplete and the practitioner must use personal clinical judgement. This should be based on recommendations or guidelines provided by authoritative groups.

NB: If you are registered with the eMJA, your username is the email address you have provided.
If you don't have a login, click here for subscription options. You will be prompted to create an account upon purchase.

AMA members can login using their AMA username and password.
If you don't know your AMA password, please contact the AMA on 02 6270 5400 or membership@ama.com.au, or try to retrieve your password at this address.

The Medical Journal of Australia eMJA

Username:
Password:

Password forgotten? Click here What is my username?